Metacare Co., Ltd. (118000.KS) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	48.6B	32.8B	20.2B	17.3B	19.1B
Cost of Revenue	22.6B	25.4B	12.5B	10.7B	12.6B
Gross Profit	6.6B	7.5B	7.7B	6.5B	6.5B
Operating Expenses
R&D Expense	—	—	—	1.2B	2.2B
SG&A Expense	2.8B	1.9B	1.4B	1.4B	1.9B
General & Admin Expense	203.0M	323.1M	108.2M	62.2M	98.1M
Selling & Marketing Expense	1.1B	1.5B	1.3B	1.3B	1.8B
Other Expenses	21.5B	4.3B	4.8B	3.0B	2.6B
Total Operating Expenses	23.7B	6.1B	6.2B	5.6B	6.8B
Cost and Expenses	46.3B	31.5B	18.7B	16.3B	19.3B
Operating Income (EBIT)	2.4B	1.3B	1.5B	1.0B	(300.5M)
Non-Operating
Interest Income	66.1M	207.2M	1.0B	1.2B	1.8B
Interest Expense	2.2B	2.4B	399.3M	3.3B	5.5B
Net Interest Income	(2.1B)	(2.2B)	640.8M	(2.1B)	(3.8B)
Other Non-Op Income/Expense	(3.4B)	(1.5B)	1.2B	(5.5B)	(49.3B)
Non-Operating Income (excl Interest)	3.2B	—	(1.6B)	2.0B	43.8B
EBT (Pre-Tax Income)	(1.1B)	(204.9M)	2.7B	(4.5B)	(49.6B)
Income Tax Expense	136.6M	7.0M	—	3.7M	32.7B
Bottom Line
Net Income	(1.7B)	498.2M	9.3B	(14.5B)	(49.6B)
Earnings from Cont. Ops	(1.2B)	(211.9M)	2.7B	(4.5B)	(49.6B)
Earnings from Discont. Ops	—	—	5.7B	(21.5B)	—
Bottom Line Net Income	(1.9B)	498.2M	9.3B	(14.5B)	(49.6B)
Per Share
Basic EPS	(₩124)	₩30	₩613	(₩1,380)	(₩5,905)
Diluted EPS	(₩124)	₩30	₩613	(₩1,378)	(₩5,905)
Revenue Per Share	₩2,423	₩1,911	₩1,336	₩1,638	₩2,276
Shares
Basic Shares Outstanding	20.1M	17.2M	15.1M	10.5M	8.4M
Diluted Shares Outstanding	20.1M	17.2M	15.1M	10.6M	8.4M
Profitability Metrics
EBITDA	4.5B	4.6B	6.1B	3.2B	(27.7B)
D&A	2.1B	3.3B	3.0B	4.7B	2.0B
EBIT	2.4B	1.3B	3.1B	1.0B	(29.6B)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026